treatment group – Page 5 – Communicable Diseases Research

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy

BNT162b2 백신 후 다발성 경화증 환자의 Anti-Spike IgG: 이탈리아의 탐색적 사례 대조 연구

Multicenter Study

Published on 2022-02-012022-09-11
Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

Benefits from Shortening Viral Shedding by Traditional Chinese Medicine Treatment for Moderate COVID-19: An Observational Study

Research Article

Published on 2022-02-012022-10-31
Journal: Evidence-based Complementary and Alternative Medicine : eCAM [Category] COVID-19,

Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial

Randomized Controlled Trial

Published on 2022-02-012022-10-05
Journal: Emergency medicine journal : EMJ [Category] COVID19(2023년), SARS, 임상,

[키워드] 95% CI acute respiratory distress Admission age assigned average Buenos Aires conducted control group COVID-19 death Dyspnoea Efficacy evaluate Fever had no HBO hyperbaric medicine hyperbaric oxygen hypoxaemia Inflammation interim analysis IQR mechanical respiratory mechanical ventilation median Mortality multicentre Open-label outcome Oxygen requirement oxygen supplementation Patient patients patients with COVID-19 randomised randomised controlled trial receive reduce respiratory respiratory symptom Sample size standard treatment statistically significant Support Symptom syndrome therapy time treat Treatment treatment group Trial with COVID-19
[DOI] 10.1136/emermed-2021-211253 PMC 바로가기 [Article Type] Randomized Controlled Trial

Haphazard Intentional Sampling in Survey and Allocation Studies on COVID-19 Prevalence and Vaccine Efficacy †

Article

Published on 2022-01-312022-10-31
Journal: Information Sciences [Category] COVID-19,

Bromhexine Hydrochloride Prophylaxis of COVID-19 for Medical Personnel: A Randomized Open-Label Study

Research Article

Published on 2022-01-292022-10-29
Journal: Interdisciplinary Perspectives on Infectious Diseases [Category] COVID-19,

[키워드] adverse events assigned Asymptomatic bromhexine Bromhexine hydrochloride cells Contact Control control group controls COVID-19 Endpoint enrolled Enrollment first positive hydrochloride Infection involved management Nasopharyngeal swab not differ Open-label participant Patient PCR PCR test penetration per day polymerase chain positive positive swab primary endpoint prophylactic treatment Prophylaxis Randomized reduced respiratory infection Result risk reduction SARS-CoV-2 SARS-COV-2 infection secondary significantly suggested symptomatic TMPRSS2 protease Treatment treatment group with COVID-19
[DOI] 10.1155/2022/4693121 PMC 바로가기 [Article Type] Research Article

Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial

성인의 심인성 쇼크에 대한 저용량 코르티코스테로이드 요법(COCCA): 무작위 대조 시험을 위한 연구 프로토콜

Study Protocol

Published on 2022-01-032022-09-10
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 Administered Adrenal insufficiency Adult patients all-cause mortality alteration Analysis approach Cardiogenic shock catecholamine caused characterized conducted consequence control group Corticosteroid corticosteroid therapy corticotropin discharge double-blind dysfunction effective Effectiveness Endothelial dysfunction Endpoint etomidate evaluate Evidence Fludrocortisone France Hydrocortisone hypothalamic-pituitary-adrenal axis ICU IMPROVE include Inflammation intensive care unit intention-to-treat basis intravenous intravenous bolus life-threatening low dose low-dose low-dose corticosteroid morbidity Myocardial infarction outcome Parallel Arm pathophysiological Patient Placebo placebo-controlled trial primary endpoint profile randomization Randomized Randomized controlled trial Randomly recruit recruited secondary Secondary endpoints Shock stimulation test Study protocol subgroup therapeutic therapy tissue treat Treatment treatment group Trial Trial registration
[DOI] 10.1186/s13063-021-05947-6 PMC 바로가기 [Article Type] Study Protocol

Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study

코로나19 치료를 위한 마이크로에멀젼 형태의 종자유 추출 스쿠알렌 효능 평가: 임상 연구

Controlled Clinical Trial

Published on 2022-01-012022-09-11
Journal: Journal of medical virology [Category] 임상, 치료제,

[키워드] Admission adverse effect adverse effects age baseline characteristics blinded change clinical study clinical trial Computed tomography Control control groups controls cough COVID-19 COVID-19 patient COVID-19 patients CT scan Efficacy emergency department evaluated Evaluating Fever Gender group High-resolution Infection Inflammation Intervention intravenous Laboratory test lung lymphocyte Lymphocyte count microemulsion nanostructure need for oxygen oxygen Oxygen therapy performed Potential treatment pumpkin seed oil required significantly squalene squalene. standard treatment study groups subjects therapy Treatment treatment group twice a day underlying diseases White blood cell White blood cells
[DOI] 10.1002/jmv.27273 PMC 바로가기 [Article Type] Controlled Clinical Trial

Nudges for COVID-19 voluntary vaccination: How to explain peer information?

Randomized Controlled Trial

Published on 2022-01-012022-10-05
Journal: Social science & medicine (1982) [Category] SARS, 임상,

[키워드] assigned autonomous Autonomy baseline Behavioral public policy conducted control group COVID-19 COVID-19 vaccine Effect effective emotional experiment explain Framing effect Government had no Herd herd immunity information Intention Japan Nudge Older Randomly receive survey Survey experiment targets the vaccine treatment group vaccination vaccination intention Vaccine
[DOI] 10.1016/j.socscimed.2021.114561 PMC 바로가기 [Article Type] Randomized Controlled Trial

No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

여성의 COVID-19 관련 결과와 항 결핵 약물의 연관성 없음 : 전국 코호트 연구

Multicenter Study

Published on 2022-01-012022-08-31
Journal: Osteoporosis international : a journal established [Category] MERS, SARS, 치료제,

[키워드] 1:1 Admission Alter Analysis analyzed association bisphosphonate Bisphosphonates cohort study control groups control patient COVID-19 COVID-19 infection Denosumab diagnosed with COVID-19 drug drugs evaluate Hospitalization ICU ICU admission independent individual intensive care intensive care unit admission lower risk Ministry of Health Mortality mortality rate mortality rates multicenter Multivariate analysis not altered Older Osteoporosis outcome outcomes Patient patients with COVID-19 positive Primary outcome Primary outcomes receiving reported Result retrieved retrospective cohort risk teriparatide Teriparatide. Treatment treatment group was performed with COVID-19 women
[DOI] 10.1007/s00198-021-06067-2 PMC 바로가기 [Article Type] Multicenter Study

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Randomized Controlled Trial

Published on 2022-01-012022-10-05
Journal: The Lancet. Global health [Category] Fulltext, SARS, 신약개발, 임상, 치료법,

[키워드] 1:1 95% CI Abstract Adaptive platform trial adverse event age Analysis Arm assigned average Bayesian Bayesian credible interval BCI Brazil Care clinical trial composite endpoint COVID-19 COVID-19 emergency death defined diagnosed early treatment Effect Efficacy eligible patient events Evidence female finding foundation groups hospital hospitalisation hospitalisations indicate initiated intention to treat intention-to-treat analysis Intervention material modified intention-to-treat no significant difference Odds ratio Outpatient participant Patient per-protocol analysis per-protocol population Placebo placebo-controlled platform positive potential participant Primary outcome Probability progression proportion protocol randomisation randomised Randomly receiving recent reduced Registered reported risk risk factor SARS-CoV-2 screened severe disease symptomatic symptomatic patient the placebo group therapeutic threshold transfer transferred translation Treatment treatment allocation treatment group Trial with COVID-19
[DOI] 10.1016/S2214-109X(21)00448-4 PMC 바로가기 [Article Type] Randomized Controlled Trial